However, the survival analysis in this study suggested no significant influence of CKS2 expression on prognosis of endometrial carcinoma patients; thus, whether CKS2 expression carries a prognostic value for predicting the survival time of endometrial carcinoma patients needed to be explored with larger cohorts in future studies. This evidence concerns the gene CKS2 and endometrial carcinoma.